Pfizer and BioNTech's vaccine is highly effective in preventing Covid-19 and there are no safety concerns that would prevent the shot from being granted an emergency-use authorization, according to a U.S. Food and Drug Administration staff report. Bloomberg's Michelle Cortez has the latest on "Bloomberg Surveillance." (Source: Bloomberg)